nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—AGTR1—ACE Inhibitor Pathway—MAS1—glaucoma	0.0131	0.154	CbGpPWpGaD
Olmesartan—AGTR1—ACE Inhibitor Pathway—ACE2—glaucoma	0.00995	0.117	CbGpPWpGaD
Olmesartan—ABCC2—ABC-family proteins mediated transport—PEX19—glaucoma	0.00666	0.0783	CbGpPWpGaD
Olmesartan—AGTR1—ACE Inhibitor Pathway—NOS3—glaucoma	0.00219	0.0258	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—OPN4—glaucoma	0.00176	0.0207	CbGpPWpGaD
Olmesartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00159	0.0187	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—PTGFR—glaucoma	0.00159	0.0187	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00158	0.0185	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00149	0.0175	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00142	0.0167	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00136	0.016	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.00129	0.0152	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00123	0.0144	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00117	0.0137	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FN1—glaucoma	0.00116	0.0137	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00105	0.0124	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL1A—glaucoma	0.00105	0.0123	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—glaucoma	0.000986	0.0116	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—SLC6A13—glaucoma	0.000979	0.0115	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—PEX19—glaucoma	0.000972	0.0114	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—FAS—glaucoma	0.000932	0.011	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—glaucoma	0.000924	0.0109	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—C3—glaucoma	0.000919	0.0108	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—OPN4—glaucoma	0.000889	0.0105	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000868	0.0102	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000862	0.0101	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—TXN—glaucoma	0.000804	0.00945	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—PTGFR—glaucoma	0.000801	0.00942	CbGpPWpGaD
Olmesartan—Vision blurred—Clonidine—glaucoma	0.000761	0.000832	CcSEcCtD
Olmesartan—Decreased appetite—Dorzolamide—glaucoma	0.000759	0.00083	CcSEcCtD
Olmesartan—Erectile dysfunction—Timolol—glaucoma	0.000759	0.00083	CcSEcCtD
Olmesartan—Urticaria—Acetazolamide—glaucoma	0.000757	0.000827	CcSEcCtD
Olmesartan—Dyspepsia—Brinzolamide—glaucoma	0.000756	0.000826	CcSEcCtD
Olmesartan—Pruritus—Apraclonidine—glaucoma	0.000754	0.000824	CcSEcCtD
Olmesartan—Body temperature increased—Acetazolamide—glaucoma	0.000753	0.000823	CcSEcCtD
Olmesartan—Fatigue—Dorzolamide—glaucoma	0.000753	0.000823	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000752	0.000822	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Travoprost—glaucoma	0.000751	0.00082	CcSEcCtD
Olmesartan—Fatigue—Travoprost—glaucoma	0.00075	0.000819	CcSEcCtD
Olmesartan—Ill-defined disorder—Clonidine—glaucoma	0.000749	0.000819	CcSEcCtD
Olmesartan—Pain—Dorzolamide—glaucoma	0.000747	0.000816	CcSEcCtD
Olmesartan—Insomnia—Pilocarpine—glaucoma	0.000746	0.000816	CcSEcCtD
Olmesartan—Decreased appetite—Brinzolamide—glaucoma	0.000746	0.000816	CcSEcCtD
Olmesartan—Pain—Travoprost—glaucoma	0.000744	0.000813	CcSEcCtD
Olmesartan—Constipation—Travoprost—glaucoma	0.000744	0.000813	CcSEcCtD
Olmesartan—Hyperglycaemia—Timolol—glaucoma	0.000743	0.000813	CcSEcCtD
Olmesartan—Agitation—Clonidine—glaucoma	0.000742	0.000811	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000741	0.00081	CcSEcCtD
Olmesartan—Asthenia—Bimatoprost—glaucoma	0.000741	0.00081	CcSEcCtD
Olmesartan—Fatigue—Brinzolamide—glaucoma	0.00074	0.000809	CcSEcCtD
Olmesartan—Angioedema—Clonidine—glaucoma	0.000738	0.000806	CcSEcCtD
Olmesartan—Pain—Brinzolamide—glaucoma	0.000734	0.000802	CcSEcCtD
Olmesartan—Angiopathy—Betaxolol—glaucoma	0.000733	0.000801	CcSEcCtD
Olmesartan—Pruritus—Bimatoprost—glaucoma	0.000731	0.000799	CcSEcCtD
Olmesartan—Diarrhoea—Apraclonidine—glaucoma	0.000729	0.000796	CcSEcCtD
Olmesartan—Malaise—Clonidine—glaucoma	0.000728	0.000796	CcSEcCtD
Olmesartan—Mediastinal disorder—Betaxolol—glaucoma	0.000728	0.000795	CcSEcCtD
Olmesartan—Dyspepsia—Pilocarpine—glaucoma	0.000726	0.000794	CcSEcCtD
Olmesartan—Syncope—Clonidine—glaucoma	0.000724	0.000791	CcSEcCtD
Olmesartan—Arrhythmia—Betaxolol—glaucoma	0.000721	0.000788	CcSEcCtD
Olmesartan—Feeling abnormal—Dorzolamide—glaucoma	0.00072	0.000787	CcSEcCtD
Olmesartan—Decreased appetite—Pilocarpine—glaucoma	0.000717	0.000784	CcSEcCtD
Olmesartan—Feeling abnormal—Travoprost—glaucoma	0.000717	0.000783	CcSEcCtD
Olmesartan—ABCC2—NRF2 pathway—SLC6A1—glaucoma	0.000716	0.00843	CbGpPWpGaD
Olmesartan—Gastrointestinal pain—Dorzolamide—glaucoma	0.000714	0.00078	CcSEcCtD
Olmesartan—Alopecia—Betaxolol—glaucoma	0.000714	0.00078	CcSEcCtD
Olmesartan—Palpitations—Clonidine—glaucoma	0.000714	0.00078	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000712	0.000779	CcSEcCtD
Olmesartan—Gastrointestinal pain—Travoprost—glaucoma	0.000711	0.000777	CcSEcCtD
Olmesartan—Loss of consciousness—Clonidine—glaucoma	0.00071	0.000776	CcSEcCtD
Olmesartan—Feeling abnormal—Brinzolamide—glaucoma	0.000707	0.000773	CcSEcCtD
Olmesartan—Mental disorder—Betaxolol—glaucoma	0.000707	0.000773	CcSEcCtD
Olmesartan—Pain—Pilocarpine—glaucoma	0.000706	0.000771	CcSEcCtD
Olmesartan—Constipation—Pilocarpine—glaucoma	0.000706	0.000771	CcSEcCtD
Olmesartan—Cough—Clonidine—glaucoma	0.000705	0.00077	CcSEcCtD
Olmesartan—Dizziness—Apraclonidine—glaucoma	0.000704	0.00077	CcSEcCtD
Olmesartan—Malnutrition—Betaxolol—glaucoma	0.000703	0.000768	CcSEcCtD
Olmesartan—ABCC2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000696	0.00818	CbGpPWpGaD
Olmesartan—Urticaria—Dorzolamide—glaucoma	0.000694	0.000758	CcSEcCtD
Olmesartan—Body temperature increased—Dorzolamide—glaucoma	0.00069	0.000755	CcSEcCtD
Olmesartan—Abdominal pain—Dorzolamide—glaucoma	0.00069	0.000755	CcSEcCtD
Olmesartan—Sinusitis—Timolol—glaucoma	0.000689	0.000754	CcSEcCtD
Olmesartan—Arthralgia—Clonidine—glaucoma	0.000687	0.000751	CcSEcCtD
Olmesartan—Chest pain—Clonidine—glaucoma	0.000687	0.000751	CcSEcCtD
Olmesartan—Abdominal pain—Travoprost—glaucoma	0.000687	0.000751	CcSEcCtD
Olmesartan—Agranulocytosis—Timolol—glaucoma	0.000686	0.00075	CcSEcCtD
Olmesartan—Anxiety—Clonidine—glaucoma	0.000685	0.000749	CcSEcCtD
Olmesartan—Asthenia—Acetazolamide—glaucoma	0.000684	0.000747	CcSEcCtD
Olmesartan—Dizziness—Bimatoprost—glaucoma	0.000683	0.000746	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000683	0.000746	CcSEcCtD
Olmesartan—Urticaria—Brinzolamide—glaucoma	0.000682	0.000745	CcSEcCtD
Olmesartan—Feeling abnormal—Pilocarpine—glaucoma	0.00068	0.000743	CcSEcCtD
Olmesartan—Discomfort—Clonidine—glaucoma	0.000679	0.000742	CcSEcCtD
Olmesartan—Vomiting—Apraclonidine—glaucoma	0.000677	0.00074	CcSEcCtD
Olmesartan—Muscle spasms—Betaxolol—glaucoma	0.000676	0.000739	CcSEcCtD
Olmesartan—Gastrointestinal pain—Pilocarpine—glaucoma	0.000675	0.000737	CcSEcCtD
Olmesartan—Dermatitis—Apraclonidine—glaucoma	0.000671	0.000733	CcSEcCtD
Olmesartan—Headache—Apraclonidine—glaucoma	0.000667	0.000729	CcSEcCtD
Olmesartan—Vision blurred—Betaxolol—glaucoma	0.000662	0.000724	CcSEcCtD
Olmesartan—Rhinitis—Timolol—glaucoma	0.000661	0.000723	CcSEcCtD
Olmesartan—Oedema—Clonidine—glaucoma	0.000659	0.00072	CcSEcCtD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000657	0.00772	CbGpPWpGaD
Olmesartan—Asthenia—Brimonidine—glaucoma	0.000656	0.000717	CcSEcCtD
Olmesartan—Infection—Clonidine—glaucoma	0.000655	0.000716	CcSEcCtD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000653	0.00768	CbGpPWpGaD
Olmesartan—Body temperature increased—Pilocarpine—glaucoma	0.000652	0.000713	CcSEcCtD
Olmesartan—Abdominal pain—Pilocarpine—glaucoma	0.000652	0.000713	CcSEcCtD
Olmesartan—Ill-defined disorder—Betaxolol—glaucoma	0.000652	0.000713	CcSEcCtD
Olmesartan—Diarrhoea—Acetazolamide—glaucoma	0.000652	0.000712	CcSEcCtD
Olmesartan—Rash—Bimatoprost—glaucoma	0.000651	0.000712	CcSEcCtD
Olmesartan—Dermatitis—Bimatoprost—glaucoma	0.000651	0.000711	CcSEcCtD
Olmesartan—Oedema peripheral—Timolol—glaucoma	0.00065	0.00071	CcSEcCtD
Olmesartan—Anaemia—Betaxolol—glaucoma	0.00065	0.00071	CcSEcCtD
Olmesartan—Shock—Clonidine—glaucoma	0.000648	0.000709	CcSEcCtD
Olmesartan—Connective tissue disorder—Timolol—glaucoma	0.000648	0.000709	CcSEcCtD
Olmesartan—Pruritus—Brimonidine—glaucoma	0.000647	0.000707	CcSEcCtD
Olmesartan—Headache—Bimatoprost—glaucoma	0.000647	0.000707	CcSEcCtD
Olmesartan—Nervous system disorder—Clonidine—glaucoma	0.000646	0.000706	CcSEcCtD
Olmesartan—Thrombocytopenia—Clonidine—glaucoma	0.000645	0.000705	CcSEcCtD
Olmesartan—Tachycardia—Clonidine—glaucoma	0.000643	0.000703	CcSEcCtD
Olmesartan—Skin disorder—Clonidine—glaucoma	0.00064	0.0007	CcSEcCtD
Olmesartan—Hyperhidrosis—Clonidine—glaucoma	0.000637	0.000696	CcSEcCtD
Olmesartan—Malaise—Betaxolol—glaucoma	0.000634	0.000693	CcSEcCtD
Olmesartan—Nausea—Apraclonidine—glaucoma	0.000633	0.000691	CcSEcCtD
Olmesartan—Vertigo—Betaxolol—glaucoma	0.000632	0.00069	CcSEcCtD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000631	0.00742	CbGpPWpGaD
Olmesartan—Syncope—Betaxolol—glaucoma	0.00063	0.000689	CcSEcCtD
Olmesartan—Dizziness—Acetazolamide—glaucoma	0.00063	0.000689	CcSEcCtD
Olmesartan—Anorexia—Clonidine—glaucoma	0.000628	0.000687	CcSEcCtD
Olmesartan—Asthenia—Dorzolamide—glaucoma	0.000627	0.000685	CcSEcCtD
Olmesartan—Asthenia—Travoprost—glaucoma	0.000624	0.000682	CcSEcCtD
Olmesartan—Palpitations—Betaxolol—glaucoma	0.000621	0.000679	CcSEcCtD
Olmesartan—Pruritus—Dorzolamide—glaucoma	0.000618	0.000675	CcSEcCtD
Olmesartan—Loss of consciousness—Betaxolol—glaucoma	0.000618	0.000675	CcSEcCtD
Olmesartan—Asthenia—Brinzolamide—glaucoma	0.000616	0.000673	CcSEcCtD
Olmesartan—Hypotension—Clonidine—glaucoma	0.000616	0.000673	CcSEcCtD
Olmesartan—Pruritus—Travoprost—glaucoma	0.000615	0.000672	CcSEcCtD
Olmesartan—Cough—Betaxolol—glaucoma	0.000613	0.00067	CcSEcCtD
Olmesartan—Nausea—Bimatoprost—glaucoma	0.000613	0.00067	CcSEcCtD
Olmesartan—Pruritus—Brinzolamide—glaucoma	0.000607	0.000664	CcSEcCtD
Olmesartan—Vomiting—Acetazolamide—glaucoma	0.000606	0.000662	CcSEcCtD
Olmesartan—Dizziness—Brimonidine—glaucoma	0.000605	0.000661	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Clonidine—glaucoma	0.0006	0.000656	CcSEcCtD
Olmesartan—Angiopathy—Timolol—glaucoma	0.000599	0.000654	CcSEcCtD
Olmesartan—Arthralgia—Betaxolol—glaucoma	0.000598	0.000654	CcSEcCtD
Olmesartan—Myalgia—Betaxolol—glaucoma	0.000598	0.000654	CcSEcCtD
Olmesartan—Chest pain—Betaxolol—glaucoma	0.000598	0.000654	CcSEcCtD
Olmesartan—Diarrhoea—Dorzolamide—glaucoma	0.000598	0.000653	CcSEcCtD
Olmesartan—Headache—Acetazolamide—glaucoma	0.000597	0.000652	CcSEcCtD
Olmesartan—Anxiety—Betaxolol—glaucoma	0.000596	0.000652	CcSEcCtD
Olmesartan—Insomnia—Clonidine—glaucoma	0.000596	0.000651	CcSEcCtD
Olmesartan—Diarrhoea—Travoprost—glaucoma	0.000595	0.00065	CcSEcCtD
Olmesartan—Mediastinal disorder—Timolol—glaucoma	0.000595	0.00065	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000594	0.00065	CcSEcCtD
Olmesartan—Asthenia—Pilocarpine—glaucoma	0.000592	0.000647	CcSEcCtD
Olmesartan—Discomfort—Betaxolol—glaucoma	0.000591	0.000646	CcSEcCtD
Olmesartan—Arrhythmia—Timolol—glaucoma	0.000589	0.000644	CcSEcCtD
Olmesartan—Diarrhoea—Brinzolamide—glaucoma	0.000587	0.000642	CcSEcCtD
Olmesartan—ABCC2—NRF2 pathway—TGFB2—glaucoma	0.000584	0.00687	CbGpPWpGaD
Olmesartan—Pruritus—Pilocarpine—glaucoma	0.000584	0.000638	CcSEcCtD
Olmesartan—Alopecia—Timolol—glaucoma	0.000583	0.000637	CcSEcCtD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000579	0.00681	CbGpPWpGaD
Olmesartan—Mental disorder—Timolol—glaucoma	0.000578	0.000632	CcSEcCtD
Olmesartan—Dizziness—Dorzolamide—glaucoma	0.000577	0.000631	CcSEcCtD
Olmesartan—Rash—Brimonidine—glaucoma	0.000577	0.00063	CcSEcCtD
Olmesartan—Dermatitis—Brimonidine—glaucoma	0.000576	0.00063	CcSEcCtD
Olmesartan—Dizziness—Travoprost—glaucoma	0.000575	0.000628	CcSEcCtD
Olmesartan—Malnutrition—Timolol—glaucoma	0.000574	0.000628	CcSEcCtD
Olmesartan—Oedema—Betaxolol—glaucoma	0.000574	0.000627	CcSEcCtD
Olmesartan—Headache—Brimonidine—glaucoma	0.000573	0.000626	CcSEcCtD
Olmesartan—Decreased appetite—Clonidine—glaucoma	0.000573	0.000626	CcSEcCtD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—glaucoma	0.00057	0.00671	CbGpPWpGaD
Olmesartan—Infection—Betaxolol—glaucoma	0.00057	0.000623	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Clonidine—glaucoma	0.000569	0.000622	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000569	0.00669	CbGpPWpGaD
Olmesartan—Fatigue—Clonidine—glaucoma	0.000568	0.000621	CcSEcCtD
Olmesartan—Dizziness—Brinzolamide—glaucoma	0.000568	0.000621	CcSEcCtD
Olmesartan—Nausea—Acetazolamide—glaucoma	0.000566	0.000619	CcSEcCtD
Olmesartan—Diarrhoea—Pilocarpine—glaucoma	0.000565	0.000617	CcSEcCtD
Olmesartan—Shock—Betaxolol—glaucoma	0.000564	0.000617	CcSEcCtD
Olmesartan—Pain—Clonidine—glaucoma	0.000564	0.000616	CcSEcCtD
Olmesartan—Constipation—Clonidine—glaucoma	0.000564	0.000616	CcSEcCtD
Olmesartan—Nervous system disorder—Betaxolol—glaucoma	0.000563	0.000615	CcSEcCtD
Olmesartan—Thrombocytopenia—Betaxolol—glaucoma	0.000562	0.000614	CcSEcCtD
Olmesartan—Tachycardia—Betaxolol—glaucoma	0.00056	0.000612	CcSEcCtD
Olmesartan—Skin disorder—Betaxolol—glaucoma	0.000557	0.000609	CcSEcCtD
Olmesartan—Vomiting—Dorzolamide—glaucoma	0.000555	0.000607	CcSEcCtD
Olmesartan—Hyperhidrosis—Betaxolol—glaucoma	0.000555	0.000606	CcSEcCtD
Olmesartan—Rash—Dorzolamide—glaucoma	0.000551	0.000602	CcSEcCtD
Olmesartan—Dermatitis—Dorzolamide—glaucoma	0.00055	0.000601	CcSEcCtD
Olmesartan—Rash—Travoprost—glaucoma	0.000548	0.000599	CcSEcCtD
Olmesartan—Dermatitis—Travoprost—glaucoma	0.000548	0.000599	CcSEcCtD
Olmesartan—Headache—Dorzolamide—glaucoma	0.000547	0.000598	CcSEcCtD
Olmesartan—Anorexia—Betaxolol—glaucoma	0.000547	0.000598	CcSEcCtD
Olmesartan—Vomiting—Brinzolamide—glaucoma	0.000546	0.000597	CcSEcCtD
Olmesartan—Dizziness—Pilocarpine—glaucoma	0.000546	0.000596	CcSEcCtD
Olmesartan—Headache—Travoprost—glaucoma	0.000545	0.000595	CcSEcCtD
Olmesartan—Nausea—Brimonidine—glaucoma	0.000543	0.000594	CcSEcCtD
Olmesartan—Feeling abnormal—Clonidine—glaucoma	0.000543	0.000593	CcSEcCtD
Olmesartan—Rash—Brinzolamide—glaucoma	0.000541	0.000592	CcSEcCtD
Olmesartan—Vision blurred—Timolol—glaucoma	0.000541	0.000592	CcSEcCtD
Olmesartan—Dermatitis—Brinzolamide—glaucoma	0.000541	0.000591	CcSEcCtD
Olmesartan—Gastrointestinal pain—Clonidine—glaucoma	0.000539	0.000589	CcSEcCtD
Olmesartan—Headache—Brinzolamide—glaucoma	0.000538	0.000588	CcSEcCtD
Olmesartan—Hypotension—Betaxolol—glaucoma	0.000536	0.000586	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—CA5A—glaucoma	0.000536	0.0063	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NARFL—glaucoma	0.000536	0.0063	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—EDN1—glaucoma	0.000528	0.00621	CbGpPWpGaD
Olmesartan—Angioedema—Timolol—glaucoma	0.000525	0.000573	CcSEcCtD
Olmesartan—Vomiting—Pilocarpine—glaucoma	0.000525	0.000573	CcSEcCtD
Olmesartan—Urticaria—Clonidine—glaucoma	0.000524	0.000572	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000523	0.000571	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—EDN1—glaucoma	0.000521	0.00613	CbGpPWpGaD
Olmesartan—Abdominal pain—Clonidine—glaucoma	0.000521	0.000569	CcSEcCtD
Olmesartan—Body temperature increased—Clonidine—glaucoma	0.000521	0.000569	CcSEcCtD
Olmesartan—Rash—Pilocarpine—glaucoma	0.00052	0.000569	CcSEcCtD
Olmesartan—Dermatitis—Pilocarpine—glaucoma	0.00052	0.000568	CcSEcCtD
Olmesartan—Insomnia—Betaxolol—glaucoma	0.000519	0.000567	CcSEcCtD
Olmesartan—Nausea—Dorzolamide—glaucoma	0.000519	0.000567	CcSEcCtD
Olmesartan—Headache—Pilocarpine—glaucoma	0.000517	0.000565	CcSEcCtD
Olmesartan—Nausea—Travoprost—glaucoma	0.000516	0.000564	CcSEcCtD
Olmesartan—Vertigo—Timolol—glaucoma	0.000516	0.000564	CcSEcCtD
Olmesartan—Syncope—Timolol—glaucoma	0.000515	0.000563	CcSEcCtD
Olmesartan—Nausea—Brinzolamide—glaucoma	0.00051	0.000557	CcSEcCtD
Olmesartan—Palpitations—Timolol—glaucoma	0.000507	0.000555	CcSEcCtD
Olmesartan—Dyspepsia—Betaxolol—glaucoma	0.000505	0.000552	CcSEcCtD
Olmesartan—Loss of consciousness—Timolol—glaucoma	0.000505	0.000552	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—OPN4—glaucoma	0.000503	0.00591	CbGpPWpGaD
Olmesartan—Cough—Timolol—glaucoma	0.000501	0.000548	CcSEcCtD
Olmesartan—Decreased appetite—Betaxolol—glaucoma	0.000499	0.000545	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Betaxolol—glaucoma	0.000495	0.000541	CcSEcCtD
Olmesartan—Fatigue—Betaxolol—glaucoma	0.000495	0.000541	CcSEcCtD
Olmesartan—Constipation—Betaxolol—glaucoma	0.000491	0.000536	CcSEcCtD
Olmesartan—Pain—Betaxolol—glaucoma	0.000491	0.000536	CcSEcCtD
Olmesartan—Nausea—Pilocarpine—glaucoma	0.00049	0.000536	CcSEcCtD
Olmesartan—Myalgia—Timolol—glaucoma	0.000489	0.000534	CcSEcCtD
Olmesartan—Chest pain—Timolol—glaucoma	0.000489	0.000534	CcSEcCtD
Olmesartan—Arthralgia—Timolol—glaucoma	0.000489	0.000534	CcSEcCtD
Olmesartan—Anxiety—Timolol—glaucoma	0.000487	0.000532	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000486	0.000531	CcSEcCtD
Olmesartan—Discomfort—Timolol—glaucoma	0.000483	0.000528	CcSEcCtD
Olmesartan—Asthenia—Clonidine—glaucoma	0.000473	0.000517	CcSEcCtD
Olmesartan—Feeling abnormal—Betaxolol—glaucoma	0.000473	0.000517	CcSEcCtD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000472	0.00555	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00047	0.00553	CbGpPWpGaD
Olmesartan—Oedema—Timolol—glaucoma	0.000469	0.000512	CcSEcCtD
Olmesartan—Anaphylactic shock—Timolol—glaucoma	0.000469	0.000512	CcSEcCtD
Olmesartan—Pruritus—Clonidine—glaucoma	0.000466	0.00051	CcSEcCtD
Olmesartan—Infection—Timolol—glaucoma	0.000466	0.000509	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—VEGFA—glaucoma	0.000462	0.00543	CbGpPWpGaD
Olmesartan—Shock—Timolol—glaucoma	0.000461	0.000504	CcSEcCtD
Olmesartan—Nervous system disorder—Timolol—glaucoma	0.00046	0.000502	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—OPN4—glaucoma	0.000456	0.00537	CbGpPWpGaD
Olmesartan—Urticaria—Betaxolol—glaucoma	0.000456	0.000498	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—C3—glaucoma	0.000455	0.00535	CbGpPWpGaD
Olmesartan—Skin disorder—Timolol—glaucoma	0.000455	0.000498	CcSEcCtD
Olmesartan—Body temperature increased—Betaxolol—glaucoma	0.000454	0.000496	CcSEcCtD
Olmesartan—Hyperhidrosis—Timolol—glaucoma	0.000453	0.000495	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—PTGFR—glaucoma	0.000452	0.00532	CbGpPWpGaD
Olmesartan—Diarrhoea—Clonidine—glaucoma	0.000451	0.000493	CcSEcCtD
Olmesartan—Anorexia—Timolol—glaucoma	0.000447	0.000488	CcSEcCtD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000441	0.00519	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000438	0.00515	CbGpPWpGaD
Olmesartan—Hypotension—Timolol—glaucoma	0.000438	0.000479	CcSEcCtD
Olmesartan—Dizziness—Clonidine—glaucoma	0.000436	0.000476	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Timolol—glaucoma	0.000427	0.000467	CcSEcCtD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000424	0.00499	CbGpPWpGaD
Olmesartan—Insomnia—Timolol—glaucoma	0.000424	0.000463	CcSEcCtD
Olmesartan—Vomiting—Clonidine—glaucoma	0.000419	0.000458	CcSEcCtD
Olmesartan—Rash—Clonidine—glaucoma	0.000415	0.000454	CcSEcCtD
Olmesartan—Dermatitis—Clonidine—glaucoma	0.000415	0.000454	CcSEcCtD
Olmesartan—Headache—Clonidine—glaucoma	0.000413	0.000451	CcSEcCtD
Olmesartan—Dyspepsia—Timolol—glaucoma	0.000413	0.000451	CcSEcCtD
Olmesartan—Asthenia—Betaxolol—glaucoma	0.000412	0.00045	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—PTGFR—glaucoma	0.000411	0.00483	CbGpPWpGaD
Olmesartan—Decreased appetite—Timolol—glaucoma	0.000407	0.000445	CcSEcCtD
Olmesartan—Pruritus—Betaxolol—glaucoma	0.000406	0.000444	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Timolol—glaucoma	0.000405	0.000442	CcSEcCtD
Olmesartan—Fatigue—Timolol—glaucoma	0.000404	0.000442	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—SMO—glaucoma	0.000404	0.00475	CbGpPWpGaD
Olmesartan—Pain—Timolol—glaucoma	0.000401	0.000438	CcSEcCtD
Olmesartan—ABCC2—NRF2 pathway—GSTM1—glaucoma	0.000397	0.00467	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—TNF—glaucoma	0.000396	0.00465	CbGpPWpGaD
Olmesartan—Diarrhoea—Betaxolol—glaucoma	0.000393	0.000429	CcSEcCtD
Olmesartan—Nausea—Clonidine—glaucoma	0.000391	0.000428	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—LRP12—glaucoma	0.000389	0.00457	CbGpPWpGaD
Olmesartan—Feeling abnormal—Timolol—glaucoma	0.000386	0.000422	CcSEcCtD
Olmesartan—Gastrointestinal pain—Timolol—glaucoma	0.000383	0.000419	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000382	0.00449	CbGpPWpGaD
Olmesartan—Dizziness—Betaxolol—glaucoma	0.000379	0.000415	CcSEcCtD
Olmesartan—Urticaria—Timolol—glaucoma	0.000372	0.000407	CcSEcCtD
Olmesartan—Abdominal pain—Timolol—glaucoma	0.000371	0.000405	CcSEcCtD
Olmesartan—Body temperature increased—Timolol—glaucoma	0.000371	0.000405	CcSEcCtD
Olmesartan—Vomiting—Betaxolol—glaucoma	0.000365	0.000399	CcSEcCtD
Olmesartan—Rash—Betaxolol—glaucoma	0.000362	0.000395	CcSEcCtD
Olmesartan—Dermatitis—Betaxolol—glaucoma	0.000361	0.000395	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—NARFL—glaucoma	0.00036	0.00423	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CA5A—glaucoma	0.00036	0.00423	CbGpPWpGaD
Olmesartan—Headache—Betaxolol—glaucoma	0.000359	0.000393	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00035	0.00411	CbGpPWpGaD
Olmesartan—Nausea—Betaxolol—glaucoma	0.000341	0.000372	CcSEcCtD
Olmesartan—Asthenia—Timolol—glaucoma	0.000336	0.000368	CcSEcCtD
Olmesartan—Pruritus—Timolol—glaucoma	0.000332	0.000362	CcSEcCtD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000321	0.00377	CbGpPWpGaD
Olmesartan—Diarrhoea—Timolol—glaucoma	0.000321	0.00035	CcSEcCtD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000313	0.00369	CbGpPWpGaD
Olmesartan—Dizziness—Timolol—glaucoma	0.00031	0.000339	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000305	0.00359	CbGpPWpGaD
Olmesartan—Vomiting—Timolol—glaucoma	0.000298	0.000326	CcSEcCtD
Olmesartan—Rash—Timolol—glaucoma	0.000296	0.000323	CcSEcCtD
Olmesartan—Dermatitis—Timolol—glaucoma	0.000295	0.000323	CcSEcCtD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000294	0.00346	CbGpPWpGaD
Olmesartan—Headache—Timolol—glaucoma	0.000294	0.000321	CcSEcCtD
Olmesartan—Nausea—Timolol—glaucoma	0.000278	0.000304	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—OPN4—glaucoma	0.00027	0.00317	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—EDN1—glaucoma	0.000266	0.00313	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CA1—glaucoma	0.000262	0.00308	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CTSA—glaucoma	0.000253	0.00298	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HEYL—glaucoma	0.000251	0.00295	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTGFR—glaucoma	0.000243	0.00285	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CA2—glaucoma	0.000239	0.00281	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000234	0.00275	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000234	0.00275	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—C3—glaucoma	0.000233	0.00273	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000229	0.0027	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000215	0.00253	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—SMO—glaucoma	0.000207	0.00244	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RPTOR—glaucoma	0.00019	0.00223	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NCK2—glaucoma	0.000184	0.00216	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CA1—glaucoma	0.000176	0.00207	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CTSA—glaucoma	0.00017	0.002	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—TXN—glaucoma	0.000169	0.00198	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CA2—glaucoma	0.000161	0.00189	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000157	0.00185	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000157	0.00185	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HDAC9—glaucoma	0.000156	0.00184	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000154	0.00181	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000152	0.00179	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—EDN1—glaucoma	0.00015	0.00177	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EDN1—glaucoma	0.000137	0.00161	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—C3—glaucoma	0.000131	0.00155	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTT1—glaucoma	0.000131	0.00154	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SMO—glaucoma	0.000122	0.00144	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—C3—glaucoma	0.000119	0.0014	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—TXN—glaucoma	0.000113	0.00133	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NTRK2—glaucoma	0.000112	0.00132	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000105	0.00124	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP1B1—glaucoma	0.000104	0.00122	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCA1—glaucoma	0.000104	0.00122	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000103	0.00122	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000102	0.0012	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NGFR—glaucoma	9.6e-05	0.00113	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NTRK1—glaucoma	9.13e-05	0.00107	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTT1—glaucoma	8.78e-05	0.00103	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDKN2B—glaucoma	8.41e-05	0.000989	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTM1—glaucoma	8.32e-05	0.000979	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EDN1—glaucoma	8.07e-05	0.000949	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NGF—glaucoma	7.42e-05	0.000872	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MTHFR—glaucoma	7.36e-05	0.000865	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.08e-05	0.000833	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—C3—glaucoma	7.05e-05	0.000829	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP1B1—glaucoma	7e-05	0.000823	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCA1—glaucoma	7e-05	0.000823	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOE—glaucoma	6.85e-05	0.000805	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAV1—glaucoma	6.79e-05	0.000798	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOE—glaucoma	6.56e-05	0.000772	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CAV1—glaucoma	6.5e-05	0.000765	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FN1—glaucoma	6.19e-05	0.000728	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BAD—glaucoma	6.12e-05	0.000719	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTM1—glaucoma	5.59e-05	0.000658	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NOS3—glaucoma	5.13e-05	0.000603	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MTHFR—glaucoma	4.94e-05	0.000581	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOS3—glaucoma	4.92e-05	0.000578	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—glaucoma	4.69e-05	0.000552	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOE—glaucoma	4.6e-05	0.000541	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAV1—glaucoma	4.56e-05	0.000536	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDKN1B—glaucoma	4.26e-05	0.000501	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP9—glaucoma	3.94e-05	0.000464	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFA—glaucoma	3.54e-05	0.000417	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NOS3—glaucoma	3.45e-05	0.000405	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—glaucoma	3.15e-05	0.000371	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TP53—glaucoma	2.68e-05	0.000315	CbGpPWpGaD
